Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Cytokinetics (CYTK) Other Non Operating Income (2022 - 2025)

Cytokinetics (CYTK) has disclosed Other Non Operating Income for 3 consecutive years, with -$300000.0 as the latest value for Q4 2025.

  • On a quarterly basis, Other Non Operating Income changed N/A to -$300000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was -$5.7 million, a N/A change, with the full-year FY2025 number at -$200000.0, up 98.98% from a year prior.
  • Other Non Operating Income was -$300000.0 for Q4 2025 at Cytokinetics, up from -$2.8 million in the prior quarter.
  • In the past five years, Other Non Operating Income ranged from a high of $700000.0 in Q3 2024 to a low of -$3.0 million in Q2 2025.
  • A 3-year average of -$1.0 million and a median of -$300000.0 in 2025 define the central range for Other Non Operating Income.
  • Biggest YoY gain for Other Non Operating Income was 500.0% in 2025; the steepest drop was 600.0% in 2025.
  • Cytokinetics' Other Non Operating Income stood at -$2.7 million in 2022, then surged by 125.99% to $700000.0 in 2024, then crashed by 142.86% to -$300000.0 in 2025.
  • Per Business Quant, the three most recent readings for CYTK's Other Non Operating Income are -$300000.0 (Q4 2025), -$2.8 million (Q3 2025), and -$3.0 million (Q2 2025).